United Kingdom· GB-APID-3702411000001101

Zorac 0.05% gel

A tazarotene product containing tazarotene, registered in United Kingdom by Allergan Ltd. The same ATC class is registered in 4 of our 19 countries.

ATC D05AX05

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedZorac 0.05% gelATCD05AX05REGISTER NO.GB-APID-3702411000001…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Tazarotene is registered in 4 of 19 countries.

Countries holding a registration under ATC D05AX05 (tazarotene), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 2 of them publish a price we can compare per daily dose

Tazarotene · ATC D05AX05

4 / 19 countries

  • Canada
  • Finlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Tazarotene
Manufacturer
Allergan Ltd
Country
United Kingdom (GB)
ATC code
D05AX05
ATC class
Tazarotene
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5016007200157

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

35 interactions on record for tazarotene.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tazarotene · interactions on record

35 records

  • 1 severe
  • 6 moderate
  • 28 info

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • Salicylic acidD01AE12moderate
  • IsotretinoinD10AD04moderate
  • IsotretinoinD10BA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tazarotene in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tazarotene products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e70b5fd5-2501-4744-a46b-105f2260a89d
GET /v1/drugs/e70b5fd5-2501-4744-a46b-105f2260a89d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3702411000001101",
  "desc": "Zorac 0.05% gel (Allergan Ltd)",
  "form": "Cutaneous gel",
  "vpid": "35914911000001104",
  "source": "dmd",
  "vtm_id": "777682009",
  "strength": "500 microgram",
  "substance": "Tazarotene",
  "ingredient": "Tazarotene",
  "supplier_code": "2062301000001104"
}

See everything about tazarotene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.